Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Omega-3 Fatty Acids to Combat Sarcopenia
Authors not listed
Mayo Clinic · 2014
Abstract
The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2014). Omega-3 Fatty Acids to Combat Sarcopenia. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT02103842
Vancouver
Anonymous. Omega-3 Fatty Acids to Combat Sarcopenia. Mayo Clinic. 2014.
BibTeX
@misc{anon2014OmegaF,
title = {Omega-3 Fatty Acids to Combat Sarcopenia},
author = {Anonymous},
journal = {Mayo Clinic},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Washington University School of Medicine 2011
Open access · US-GOV
Omega-3 Fatty Acids, Muscle Mass and Muscle Function
University of Alabama at Birmingham 2010
Open access · US-GOV
Dietary Supplements and Aging Muscle: Specific Amino Acids to Combat Sarcopenia
University of Nottingham 2014
Open access · US-GOV
Characterizing the Incretin Effect of Amino Acids (AA) and Defining the Effect of GLP-1 on Muscle Microvascular Blood Flow and Muscle Protein and Glucose Metabolism in Older Age.
The Lancet Child & Adolescent Health 2018
Citation only
The age of adolescence
Elsevier eBooks 2010
Citation only
Sirtuins in Aging and Age-Related Diseases
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY